Novo Nordisk said on Friday the U.S. Food and Drug Administration has granted accelerated approval for its weight-loss drug ...

Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators to treat an increasingly common liver disease, MASH.

Novo Nordisk (NVO) stock in focus as the company wins FDA accelerated nod for weight loss therapy Wegovy against the liver ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an additional indication for Wegovy® ...

Yankees can mash, but playoffs will expose run prevention weakness again originally appeared on Athlon Sports. The Yankees ...

An easy, protein-packed vegetarian lunch bowl made with cauliflower rice, sweet potatoes, and a hearty chickpea salad. In ...

Here’s everything you need to know about butternut squash harvest, including timing, steps, curing, storage, and saving the ...

I am reversing my rating on Akero Therapeutics stock from Buy to Sell due to valuation concerns and a long-ish wait for ...

HistoIndex’s AI-based FibroSIGHT Plus’s launch coincides with the MASH space’s pharma market potential swelling across the ...

Amateur fossil hunter Ross Dullard, who found the partial skull, says he will celebrate with a whale-themed party, marking ...

Going up against these giants is no small challenge, but Viking is, so far, holding its own. And if it can play its cards ...

Kerry Carpenter has established a new career high with 21 homers this year. His .598 SLG vs. right-handers since the start of ...